复旦张江(01349)下跌5.3%,报2.5元/股

金融界
22 Nov 2024

11月22日,复旦张江(01349)盘中下跌5.3%,截至14:52,报2.5元/股,成交914.61万元。

上海复旦张江生物医药股份有限公司主要从事生物医药的创新研究、开发、生产和销售,致力于成为一家以知识产权为核心源泉的生物医药创新企业。公司拥有近六百名高素质的员工,且在基因工程药物、光动力药物及纳米药物等领域具有明显的竞争优势,已成功在香港主板上市,股票代码1349。

截至2024年三季报,复旦张江营业总收入5.49亿元、净利润8646.86万元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10